Physical Activity as Moderator of the Association Between APOE and Cognitive Decline in Older Adults: Results from Three Longitudinal Cohort Studies. (28th February 2020)

• Record Type: Journal Article
• Authors: Stringa, Najada; van Schoor, Natasja M; Milaneschi, Yuri; Ikram, M Arfan; Del Panta, Vieri; Koolhaas, Chantal M; Voortman, Trudy; Bandinelli, Stefania; Wolters, Frank J; Huisman, Martijn
• Editors: Newman, Anne
• Is Part Of: Journals of gerontology. Volume 75:Number 10(2020)
• Page Start: 1880
• Page End: 1886
• Publication Date: 2020-02-28
• Subjects: Gene–environment interaction -- Longitudinal Aging Study Amsterdam -- InCHIANTI -- Rotterdam Study; Geriatrics -- Periodicals; Gerontology -- Periodicals; 618.97
• DOI: 10.1093/gerona/glaa054
• Languages: English
• ISSNs: 1079-5006

Abstract

Abstract: Background: Previous studies have suggested that the association between APOE ɛ 4 and dementia is moderated by physical activity (PA), but the results remain inconclusive and longitudinal data on cognitive decline are missing. In this study, we examine whether there is a gene–environment interaction between APOE and PA on cognitive decline in older adults using 9-year follow-up data of three cohort studies. Methods: We followed 7, 176 participants from three longitudinal cohort studies: Longitudinal Aging Study Amsterdam (LASA), InCHIANTI, and Rotterdam Study for 9 years. PA was assessed with self-reported questionnaires and was categorized in low, moderate, and high PA. Cognitive function was assessed with the Mini-Mental State Examination (MMSE) and cognitive decline was defined as a decrease of three points or more on the MMSE during 3 years follow-up. We fitted logistic regression models using generalized estimating equations adjusting for age, sex, education, depressive symptoms, and number of chronic disease. Interaction between APOE and PA was tested on multiplicative and additive scale. Results: Cohorts were similar in most aspects but InCHIANTI participants were on average older and had lower education. APOE ɛ 4 carriers had higher odds of cognitive decline (odds ratio [OR] = 1.46, 95% confidence interval [CI]: 1.29–1.64) while PA was not significantly associated with cognitive decline overall (moderate PA: OR = 0.87, 0.67–1.13; high PA: OR = 0.71, 0.36–1.40). There was no evidence for an interaction effect between PA and APOE ɛ 4 in cognitive decline in older adults ( APOE × moderate PA: p = .83; APOE × high PA: p = .90). Conclusions: Previous claims of a gene–environment interaction between APOE ɛ 4 and PA in cognitive decline are not supported by our results.